Alerts will be sent to your verified email
Verify Email
VISTAPH
|
Vista Pharma
|
Mangalam Drugs&Org.
|
Panjon
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
0.0 | 1.78 % | 2.02 % |
|
5yr average Equity Multiplier
|
1.42 | 2.43 | 1.09 |
|
5yr Average Asset Turnover Ratio
|
0.08 | 1.0 | 0.85 |
|
5yr Avg Net Profit Margin
|
-205.63 % | 0.0 | -6.52 % |
|
Price to Book
|
1.03 | 0.37 | 2.65 |
|
P/E
|
0.0 | 0.0 | 59.26 |
|
5yr Avg Cash Conversion Cycle
|
124.89 Days | 17.41 Days | 77.42 Days |
|
Inventory Days
|
3040.44 Days | 132.58 Days | 126.87 Days |
|
Days Receivable
|
137.33 Days | 38.43 Days | 30.38 Days |
|
Days Payable
|
1845.08 Days | 126.53 Days | 36.87 Days |
|
5yr Average Interest Coverage Ratio
|
-2.88 | 0.9 | -9.32 |
|
5yr Avg ROCE
|
-8.17 % | 6.92 % | -4.48 % |
|
5yr Avg Operating Profit Margin
|
-192.46 % | 7.63 % | -8.95 % |
|
5 yr average Debt to Equity
|
0.26 | 0.59 | 0.09 |
|
5yr CAGR Net Profit
|
19.73 % | 39.54 % | n/a |
|
5yr Average Return on Assets
|
-6.49 % | -0.18 % | -4.21 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
21.19 % | 35.64 % | 56.69 % |
|
Share Pledged by Promoters
|
0.0 | 7.09 % | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-14.25 % | -14.68 % | 4.66 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
-0.02 % | 0.0 | 0.0 |
|
Vista Pharma
|
Mangalam Drugs&Org.
|
Panjon
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|